IDEAYA Biosciences, Inc. IDYA Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s accrued liabilities, current?
- IDEAYA Biosciences, Inc. (IDYA) reported accrued liabilities, current of $43.75M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s accrued liabilities, current changed year-over-year?
- IDEAYA Biosciences, Inc.'s accrued liabilities, current increased by 32.9% year-over-year, from $32.91M to $43.75M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s accrued liabilities, current has grown at a 36.9% compound annual growth rate (CAGR), from $8.52M to $40.89M.